TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients ; volume:23 ; number:1 ; day:28 ; month:11 ; year:2023 ; pages:1-11 ; date:12.2023
BMC cancer ; 23, Heft 1 (28.11.2023), 1-11, 12.2023
- Creator
-
Tsakmaklis, Anastasia
Farowski, Fedja
Zenner, Rafael
Lesker, Till Robin
Strowig, Till
Schlößer, Hans
Lehmann, Jonas
Bergwelt-Baildon, Michael von
Mauch, Cornelia
Schlaak, Max
Knuever, Jana
Schweinsberg, Viola
Heinzerling, Lucie M.
Vehreschild, Maria J. G. T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-11551-5
- URN
-
urn:nbn:de:101:1-2024021510572305886912
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsakmaklis, Anastasia
- Farowski, Fedja
- Zenner, Rafael
- Lesker, Till Robin
- Strowig, Till
- Schlößer, Hans
- Lehmann, Jonas
- Bergwelt-Baildon, Michael von
- Mauch, Cornelia
- Schlaak, Max
- Knuever, Jana
- Schweinsberg, Viola
- Heinzerling, Lucie M.
- Vehreschild, Maria J. G. T.
- SpringerLink (Online service)
Other Objects (12)
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma
Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma
Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma
Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma